Grant: Project Grant
University of Ottawa
$100,000.00
It is time to address fear of cancer recurrence in the family caregiver: a feasibility and acceptability study of an online version of the Fear Of Recurrence Therapy (FORT) for family caregivers.
EF 2022-23
Résumé
Fear of cancer recurrence (FCR) is common, persistent, and is associated with negative personal and societal outcomes. Studies show that family caregivers (FC) of cancer patients experience equal or greater levels of FCR than patients. In the past 5 years, several interventions have demonstrated their ability to reduce FCR among cancer patients, including a group intervention called Fear Of Recurrence Therapy (FORT), which was developed by our team, and was offered both face to face and via videoconference. However, none have ever been adapted and offered to FC. We have previously worked with an advisory board composed of researchers, clinicians, and FC to adapt our 6-week, 2-hour, cognitive-existential group therapy (the FORT intervention) to FC via videoconferencing (FC-FORT). In the present project, we want to conduct a pilot study to assess if FC 1) can be recruited at a satisfactory rate, be able to attend sessions, and are satisfied with the intervention, and 2) experience lower levels of FCR and improved tolerance for uncertainty and coping. FC-FORT will be delivered by two therapists via videoconferencing to four groups of nine adult FC of adult cancer patients. Participants will be randomized to the intervention or to a wait-list control group, in which case they will be offered the intervention after the study. Participants will be recruited directly by clinicians and by outreach mailout efforts. They will complete a questionnaire package before and after the intervention and at a 3-month follow-up. The proposed study is needed to determine if FC-FORT is feasible and acceptable before it can be successfully tested in a randomized trial. This will help bridge an important gap in bringing evidence-based care to FC who have never been offered help before for their FCR.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
477304
Name
Lebel Sophie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Psychosocial, Sociocultural & Behavioural Determinants of Health
Projecttitle
It is time to address fear of cancer recurrence in the family caregiver: a feasibility and acceptability study of an online version of the Fear Of Recurrence Therapy (FORT) for family caregivers.
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cancer; Caregivers; E-Health; Fear Of Recurrence; Intervention; Pilot Study; Survivorship
Abstract
Fear of cancer recurrence (FCR) is common, persistent, and is associated with negative personal and societal outcomes. Studies show that family caregivers (FC) of cancer patients experience equal or greater levels of FCR than patients. In the past 5 years, several interventions have demonstrated their ability to reduce FCR among cancer patients, including a group intervention called Fear Of Recurrence Therapy (FORT), which was developed by our team, and was offered both face to face and via videoconference. However, none have ever been adapted and offered to FC. We have previously worked with an advisory board composed of researchers, clinicians, and FC to adapt our 6-week, 2-hour, cognitive-existential group therapy (the FORT intervention) to FC via videoconferencing (FC-FORT). In the present project, we want to conduct a pilot study to assess if FC 1) can be recruited at a satisfactory rate, be able to attend sessions, and are satisfied with the intervention, and 2) experience lower levels of FCR and improved tolerance for uncertainty and coping. FC-FORT will be delivered by two therapists via videoconferencing to four groups of nine adult FC of adult cancer patients. Participants will be randomized to the intervention or to a wait-list control group, in which case they will be offered the intervention after the study. Participants will be recruited directly by clinicians and by outreach mailout efforts. They will complete a questionnaire package before and after the intervention and at a 3-month follow-up. The proposed study is needed to determine if FC-FORT is feasible and acceptable before it can be successfully tested in a randomized trial. This will help bridge an important gap in bringing evidence-based care to FC who have never been offered help before for their FCR.
Competitiondate
202210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lebel, Sophie; Maheu, Christine; Nissim, Rinat
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~